WuXi PharmaTech (Cayman) Inc. Retained Earnings
WuXi PharmaTech (Cayman) Inc. had Retained Earnings of $415.33 million as of 2014-12-31, per its 20-F filed 2015-04-15.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2015-04-15
- 2014-12-31: Retained Earnings (Accumulated Deficit) $415.33M.
- 2013-12-31: Retained Earnings (Accumulated Deficit) $303.17M.
- 2012-12-31: Retained Earnings (Accumulated Deficit) $188.60M.
- 2011-12-31: Retained Earnings (Accumulated Deficit) $103.16M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2014-12-31 | $415.33M 20-F · filed 2015-04-15 |
| 2013-12-31 | $303.17M 20-F · filed 2015-04-15 |
| 2012-12-31 | $188.60M 20-F · filed 2014-04-15 |
| 2011-12-31 | $103.16M 20-F · filed 2013-04-17 |
| 2010-12-31 | $22.18M 20-F · filed 2012-04-20 |
| 2009-12-31 | -$68.63M 20-F · filed 2011-04-27 |